Diabetic Foot Files

Forgotten Infection Friday — Nocardia: The Weakly Acid‑Fast Impostor

24 min · 26. juni 2026
episode Forgotten Infection Friday — Nocardia: The Weakly Acid‑Fast Impostor cover

Description

A 62-year-old man with poorly controlled diabetes presented with weeks of cough, weight loss, night sweats, and cavitary lung lesions initially suspected to be tuberculosis or malignancy. Sputum TB tests were negative and symptoms progressed. Bronchoscopic lung biopsy showed branching gram‑positive filaments that were weakly acid‑fast, consistent with Nocardia species. Nocardia commonly infects immunocompromised hosts, can disseminate to the brain, and is often mistaken for TB, fungal infection, or cancer. Diagnosis relies on modified acid‑fast stain, prolonged cultures, or molecular testing. Treatment requires prolonged antibiotic therapy (commonly TMP‑SMX), sometimes IV agents for severe disease, and early recognition in diabetic or immunosuppressed patients is critical to prevent dissemination.

Comments

0

Be the first to comment

Sign up now and become a member of the Diabetic Foot Files community!

Get Started

1 month for 9 kr.

Then 99 kr. / month · Cancel anytime.

  • Podcasts kun på Podimo
  • 20 lydbogstimer pr. måned
  • Gratis podcasts

All episodes

340 episodes

episode LIMBWatch Series: Reinventing Hydrotherapy—Jason Ayer, RN’s Topical Oxygen-Powered Approach to Limb Salvage artwork

LIMBWatch Series: Reinventing Hydrotherapy—Jason Ayer, RN’s Topical Oxygen-Powered Approach to Limb Salvage

In this episode of Limb Watch Series with Diabetic Foot Files, host interviews Jason Ayers, a wound care RN and inventor of a topical oxygen hydrotherapy kit that combines warmed antimicrobial cleansing solution with localized oxygen bubbles to cleanse and promote healing in chronic wounds, especially diabetic foot ulcers. Jason explains the origin and prototype development, demonstrates a typical 10–15 minute treatment session, and shares case-study results showing faster cleansing, improved tissue color, reduced drainage and odor, and positive patient feedback. The discussion covers how the device fits into current debridement tools, safety and infection-control design choices, and the inventor’s vision for broader clinical adoption and training to help prevent amputations and advance limb preservation.

7. juli 202647 min